A comprehensive review on efficient artificial intelligence models for classification of abnormal cardiac rhythms using electrocardiograms

Gupta, Utkarsh; Paluru, Naveen; Nankani, Deepankar; Kulkarni, Kanchan; Awasthi, Navchetan

doi:10.1016/j.heliyon.2024.e26787

Heliyon

2024

DOI: 10.1016/j.heliyon.2024.e26787

|View full text |Cite

A comprehensive review on efficient artificial intelligence models for classification of abnormal cardiac rhythms using electrocardiograms

Utkarsh Gupta,

Naveen Paluru,

Deepankar Nankani

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 149 publications

(167 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Emerging Analytical Approaches for Personalized Medicine Using Machine Learning In Pediatric and Congenital Heart Disease

Chinni,

Manlhiot

2024

Canadian Journal of Cardiology

View full text Add to dashboard Cite

Emerging Analytical Approaches for Personalized Medicine Using Machine Learning In Pediatric and Congenital Heart Disease

Chinni,

Manlhiot

2024

Canadian Journal of Cardiology

View full text Add to dashboard Cite

Drug repurposing: Clinical practices and regulatory pathways

Saranraj,

Kiran

2024

Perspectives in Clinical Research

View full text Add to dashboard Cite

Drug repurposing, also known as drug repositioning or reprofiling, involves identifying new therapeutic uses for existing drugs beyond their original indications. Historical examples include sildenafil citrate transitioning to an erectile dysfunction treatment and thalidomide shifting from a sedative to an immunomodulatory agent. Advocates tout its potential to address unmet medical needs by expediting development, reducing costs, and using drugs with established safety profiles. However, concerns exist regarding specificity for new indications, safety, and regulatory exploitation. Ethical considerations include equitable access, informed consent when using drugs off-label, and transparency. Recent advancements include artificial intelligence (AI) applications, network pharmacology, and omics technologies. Clinical trials explore repurposed drugs’ efficacy, with regulatory agencies facilitating approval. Challenges include intellectual property protection, drug target specificity, trial design complexities, and funding limitations. Ethical challenges encompass patient autonomy, potential conflicts of interest due to financial incentives for industries, and resource allocation. Future directions involve precision medicine, AI, and global collaboration. In conclusion, drug repurposing offers a promising pathway for therapeutic innovation but requires careful consideration of its complexities and ethical implications to maximize benefits and minimize risks.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A comprehensive review on efficient artificial intelligence models for classification of abnormal cardiac rhythms using electrocardiograms

Cited by 2 publications

References 149 publications

Emerging Analytical Approaches for Personalized Medicine Using Machine Learning In Pediatric and Congenital Heart Disease

Emerging Analytical Approaches for Personalized Medicine Using Machine Learning In Pediatric and Congenital Heart Disease

Drug repurposing: Clinical practices and regulatory pathways

Contact Info

Product

Resources

About